By Richard Thomas, Ibadan
The Association of Medical Laboratory Scientists of Nigeria (AMLSN) has urged the Federal Government to revitalise the medical laboratory system in the country in order to promote health security in Nigeria.
This was contained in a communique issued by the association at the end of its 2022 special general meeting held at the International Conference Centre, University of Ibadan.
Addressing newsmen at the programme, the National President of the association, Professor James Garba Damen, said the government needed to strengthen the technology in the country’s Medical Laboratory Services as requisite for continuous and improved productivity in the medical laboratories.
While applauding President Muhammadu Buhari for approving N950 million intervention fund for the establishment of Molecular Laboratories in all federal territories hospitals, Professor Damen expressed optimistic that the building and equipping of these laboratories will tremendously help in mitigating the spread of Covid-19 pandemics as well as other infectious diseases.
According to him, the Medical Laboratory capacity must begin with the upholding of the Medical Laboratory Science Council of Nigeria (MLSCN) Act 11 of 2003 which is the legal instruments and framework for the training, practice and regulation of Medical Laboratory Science practice in Nigeria.
He added that government and other healthcare professionals must, therefore, work in synergy and in the spirit of the MLSCN Act to avoid unnecessary conflict in the health sector.
He congratulated Dr. Ifedayo Adetifa on his appointment as the Director-General of the Nigeria Centre for Disease Control (NCDC), just as he urged him to eschew professional marginalization and work with all professionals in the interest of the country in the collective quest to protect Nigeria from the impact of communicable diseases.
He assured that as Medical Laboratory Scientists skilled-in knowledge and techniques of vaccines production, they are ready to start the development and production of indigenous vaccines against the novel SARS-Cov-2 and indeed all other infectious diseases.
He added that all they needed is adequate funding and necessary laboratory infrastructure.